Table 2. Patients’ demographic and baseline characteristics.
Variables | CES+CT (Group 1) (n=36) | tDCS+CT (Group 2) (n=36) | ||||||
Mean±SD | Median | Range | p | Mean±SD | Median | Range | p | |
Age (year) | 39.3±10.5 | 0.653* | 41.7±8.4 | 0.243* | ||||
Weight (kg) | 77.10±8.57 | 0.059* | 74.44±10.77 | 0.560* | ||||
Height (cm) | 167.90±4.76 | 0.060* | 169.23±4.01 | 0.577* | ||||
BMI (kg/m2) | 27.38±3.18 | 0.009 | 25.94±3.33 | 0.575* | ||||
GCS | 13 | 11-15 | 0.039 | 13 | 11-15 | 0.364* | ||
Duration of injury (days) | 5.5 | 3-9 | 0.709* | 6 | 4-12 | 0.092* | ||
MoCA at baseline | 12 | 6-18 | 0.606* | 14 | 5-20 | 0.868* | ||
GOAT at baseline | 46 | 38-58 | 0.095* | 49.5 | 31-64 | 0.171* | ||
CES: Cranial electrotherapy stimulation; CT: Cognitive training; tDCS: Transcranial direct current stimulation; SD: Standard deviation; MoCA: Montreal cognitive assessment; GOAT: Galveston orientation and amnesia teel; * Level of significance (p-value) was set at >0.05; Shapiro-Wilk test was used to analyze normality of each group. |